Published online Jul 14, 2016. doi: 10.3748/wjg.v22.i26.5950
Peer-review started: March 27, 2016
First decision: April 14, 2016
Revised: May 6, 2016
Accepted: May 21, 2016
Article in press: May 23, 2016
Published online: July 14, 2016
Processing time: 102 Days and 1.5 Hours
Core tip: Liver transplantation has become the treatment of choice for many liver diseases. It is currently a routine procedure but is still associated with significant morbidity being infectious complications the leading cause of death. Selective intestinal decontamination (SID) is a prophylactic strategy that consists of the administration of non-absorbable or systemic antibiotics with scarce anaerobicidal activity in order to prevent or minimize the impact of endogenous infections by potentially pathogenic microorganisms. In this review, we focus on the knowledge regarding the current role of SID in liver transplant recipients. Multiple studies have evaluated the role of SID in the critically ill patient, and several observational studies, randomized clinical trials and a meta-analysis have focused in liver transplantation. Our aim is to consolidate the current literature to better outline the impact of SID in the prevention of infections in this setting.
